SCA
LJPC

Secor Capital Advisors’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Secor Capital Advisors’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-12,516
Closed -$374K – 639
2017
Q1 		$374K Buy
+12,516
New +$320K 0.04% 377
2016
Q4 		– Sell
-24,010
Closed -$571K – 726
2016
Q3 		$571K Sell
24,010
-13,982
-37% -$263K 0.06% 339
2016
Q2 		$608K Buy
+37,992
New +$682K 0.08% 339

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Secor Capital Advisors's LJPC Position: Q2 2017 in Review

Secor Capital Advisors sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2017, closing a stake of 12,516 shares — an estimated $374K sold.

Secor Capital Advisors first reported a position in LJPC in Q2 2016 and held it in 3 quarters. The position peaked at $608K in Q2 2016. 83 funds tracked by Wall St. Rank hold LJPC as of Q2 2017.

  • Secor Capital Advisors reported no remaining La Jolla Pharmaceutical Company position as of Q2 2017 after selling out during the quarter.
  • Secor Capital Advisors sold 12,516 La Jolla Pharmaceutical Company shares in Q2 2017, an estimated $374K.
  • Secor Capital Advisors first reported a position in La Jolla Pharmaceutical Company in Q2 2016 and held it in 3 quarters.
  • Secor Capital Advisors's La Jolla Pharmaceutical Company position peaked at $608K in Q2 2016.
  • 83 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2017.

Based on Secor Capital Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.